Respiratory

Inhalers prescribed for asthma and COPD generated nearly 25 million metric tons of greenhouse gas emissions in the United States over the past decade.

Tezepelumab oral corticosteroid reduction in severe asthma achieved meaningful steroid sparing without loss of asthma control.

New onset interstitial lung disease has intensive care mortality matching established disease in severe respiratory failure.

Age-based lung cancer screening could detect far more cases than current US risk-based eligibility criteria.

Moderate thrombosis in lung injury may paradoxically protect sepsis related ARDS via endothelial ALOX15 driven signaling.

A modified mRNA influenza vaccine delivered superior efficacy with more reactogenicity than a licensed quadrivalent comparator.

Inhaled molgramostim improved gas transfer and quality of life in adults with autoimmune pulmonary alveolar proteinosis.

Updated NCCN Guidelines for non-small cell lung cancer (NSCLC) detail expanded systemic therapy options that strengthen outcomes for patients with resectable and unresectable disease.